BVF PARTNERS L P/IL
CIK
1055947
13D Filings
14
Companies
7
Latest Filing
Apr 2, 2026, 04:44 PM
Filing History
Company | % Owned | Type | Filed | |
|---|---|---|---|---|
MoonLake Immunotherapeutics MLTX | 22.30% ▼ -5.40% | Amendment | Apr 2, 2026, 04:44 PM | |
IMMUNIC, INC. IMUX | 9.99% | NEW | Feb 20, 2026, 06:59 PM | |
Repare Therapeutics Inc. RPTX | 0.00% ▼ -24.00% | Amendment | Jan 30, 2026, 06:39 PM | |
Kymera Therapeutics, Inc. KYMR | 8.50% | Amendment | Dec 15, 2025, 06:07 PM | |
Repare Therapeutics Inc. RPTX | 24.00% | Amendment | Nov 24, 2025, 05:05 PM | |
Inventiva S.A. IVA | 4.99% ▼ -1.11% | Amendment | Nov 19, 2025, 05:10 PM | |
MoonLake Immunotherapeutics MLTX | 27.70% | Amendment | Nov 10, 2025, 05:27 PM | |
ESSA Pharma Inc. | 0.00% ▼ -24.70% | Amendment | Oct 14, 2025, 05:30 PM | |
ESSA Pharma Inc. | 24.70% ▲ +5.00% | Amendment | Aug 7, 2025, 04:31 PM | |
XOMA Royalty Corp XOMA | 21.60% ▼ -3.70% | Amendment | May 20, 2025, 06:52 PM | |
Inventiva S.A. IVA | 6.10% ▼ -2.90% | Amendment | May 9, 2025, 05:50 PM | |
ESSA Pharma Inc. | 19.70% | NEW | Apr 9, 2025, 09:00 AM | |
XOMA Royalty Corp XOMA | 25.30% | Amendment | Jan 28, 2025, 05:19 PM | |
Inventiva S.A. IVA | 9.00% | Amendment | Dec 23, 2024, 09:25 PM | |
Rows:
20
1–14 of 14
1